Kathleen Liddell

University of Cambridge - Faculty of Law

10 West Road

Cambridge, CB3 9DZ

United Kingdom

SCHOLARLY PAPERS

22

DOWNLOADS
Rank 25,306

SSRN RANKINGS

Top 25,306

in Total Papers Downloads

2,062

SSRN CITATIONS

5

CROSSREF CITATIONS

5

Scholarly Papers (22)

1.

Immorality and Patents: The Exclusion of Inventions Contrary to Ordre Public and Morality

In A Lever (ed), New Frontiers in the Philosophy of Intellectual Property (Cambridge CUP 2012), University of Cambridge Faculty of Law Research Paper No. 55/2016
Number of pages: 27 Posted: 08 Nov 2016
Kathleen Liddell
University of Cambridge - Faculty of Law
Downloads 330 (99,874)
Citation 1

Abstract:

Loading...

Patents, Immorality, Ethics, EPC Article 53(a), EU Directive on Biotechnological Inventions, Exclusion For "Invention the Commercial Exploitation of Which Is Contrary to Morality or Order Public", Oncomouse, Embryo Stem Cell Patent

2.

COVID-19 Contact Tracing Apps: A Stress Test for Privacy, the GDPR and Data Protection Regimes

Journal of Law and the Biosciences (2020), University of Cambridge Faculty of Law Research Paper No. 23/2020
Number of pages: 21 Posted: 03 Jun 2020
Laura R. Bradford, Mateo Aboy and Kathleen Liddell
University of Cambridge - Faculty of Law, LML, University of Cambridge and University of Cambridge - Faculty of Law
Downloads 254 (134,298)

Abstract:

Loading...

data privacy, information privacy, GDPR, HIPAA, COVID-19, contact tracing, data protection

3.

Fair and Equitable Treatment and Judicial Patent Decisions

University of Cambridge Faculty of Law Research Paper No. 4/2016
Number of pages: 40 Posted: 26 Jan 2016
Kathleen Liddell and Michael Waibel
University of Cambridge - Faculty of Law and University of Vienna - Faculty of Law
Downloads 248 (135,368)
Citation 2

Abstract:

Loading...

intellectual property rights, patents, patent offices, patent invalidation, fair and equitable treatment, state responsibility for judicial conduct, deference to judicial conduct, Eli Lilly v. Canada

4.

Informed Consent for Research Using Biospecimens, Genetic Information and Other Personal Data

University of Cambridge Faculty of Law Research Paper No. 27/2017
Number of pages: 21 Posted: 15 Jun 2017 Last Revised: 03 Aug 2017
Kathleen Liddell and Jeffrey M. Skopek
University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 212 (157,443)

Abstract:

Loading...

Informed consent, Biospecimens and personal data, Genetics research, Anonymization, Anonymisation, Return of research results, Return of incidental findings, Community consent, Property rights

5.

Who Gets the Ventilator? Important Legal Rights in a Pandemic

Kathleen Liddell, Jeffrey M. Skopek, Stephanie Palmer, Stevie Martin, Jennifer Anderson, and Andrew Sagar, "Who Gets the Ventilator? Important Legal Rights in a Pandemic" Journal of Medical Ethics (May 2020), University of Cambridge Faculty of Law Research Paper No. 19/2020
Number of pages: 14 Posted: 22 Apr 2020 Last Revised: 15 May 2020
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, Faculty of Law, University of Cambridge, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 205 (162,428)

Abstract:

Loading...

COVID-19 pandemic, law, medical law, discrimination law, public law, ventilators, bioethics

6.

Precision Medicine: Legal and Ethical Challenges

University of Cambridge Faculty of Law Research Paper No. 64/2017
Number of pages: 18 Posted: 16 Nov 2017 Last Revised: 06 Dec 2017
John Liddicoat, Jeffrey M. Skopek and Kathleen Liddell
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 145 (219,675)

Abstract:

Loading...

Precision Medicine, Law, Patent Law, Regulation, Genomics, Biobanks, Tort Law, Liability, Health Systems, Ethics, Challenges, Implantation, Clinical Treatment, Foundation Research, Translational Medicine, Conference Report

7.

Should We Change EU Law to Disallow DNA Patents?

Number of pages: 10 Posted: 28 Jan 2018
Kathleen Liddell and John Liddicoat
University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 130 (239,496)
Citation 1

Abstract:

Loading...

Intellectual Property, Patent Law, DNA Patents, Gene Patents, Patent Eligibility, Patentable Subject Matter, EU Biotechnology Directive, AMP v Myriad

8.

Open Innovation with Large Bioresources: Goals, Challenges and Proposals

University of Cambridge Faculty of Law Research Paper No. 6/2017
Number of pages: 35 Posted: 23 Dec 2016 Last Revised: 19 Jan 2017
John Liddicoat and Kathleen Liddell
University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 126 (245,221)

Abstract:

Loading...

intellectual property, patents, bioresources, biobanks, synthetic biology, synbio, genomics, genomic medicine, IP policy, access policy, openness, open innovation, open science, open source

9.

The Effects of Myriad and Mayo on Molecular Test Development in the US and Europe: Interviews from the Frontline

22 Vanderbilt Journal of Entertainment & Technology Law 785, University of Cambridge Faculty of Law Research Paper 33/2019
Number of pages: 53 Posted: 29 May 2019 Last Revised: 21 May 2020
John Liddicoat, Kathleen Liddell and Mateo Aboy
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and LML, University of Cambridge
Downloads 74 (347,728)

Abstract:

Loading...

patent, patentable subject matter, patent eligibility, 35 USC 101, US, Europe, interviews, empirical, comparative

10.

Myriad's Impact on Gene Patents

Nature Biotechnology, Vol. 34, No. 11, p. 1119-1123, Nov. 2016, University of Cambridge Faculty of Law Research Paper No. 58/2017
Number of pages: 8 Posted: 04 Aug 2017 Last Revised: 25 Jun 2019
Mateo Aboy, Kathleen Liddell, John Liddicoat and Cristina Crespo
LML, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge
Downloads 69 (361,379)
Citation 1

Abstract:

Loading...

Patents, BRCA, Myriad, Gene Patents, Patent Publications, Empirical Analysis

Pre-Mortem Interventions in Donation after Circulatory Death: A Proposal for Action

University of Cambridge Faculty of Law Research Paper No. 58/2016
Number of pages: 5 Posted: 30 Nov 2016
University of Cambridge - Faculty of Law, University of Cambridge - Department of Surgery, Faculty of Law and Corpus Christi College, University of Oxford, 39 Essex Chambers, University of Cambridge - Department of Surgery and University of Cambridge - Department of Surgey
Downloads 54 (414,727)

Abstract:

Loading...

Medical Ethics, Organ Donation, Donation after Circulatory Death, DCD, Medico-Legal, Organ Transplantation, Organ Transplants, Clinical Guidelines, Organ Transplantation Law, Mental Capacity, Best Interests, Research Ethics

Pre-Mortem Interventions in Donation after Circulatory Death: A Proposal for Action

Number of pages: 4 Posted: 22 Jan 2018
University of Cambridge - Faculty of Law, University of Cambridge - Department of Surgery, Faculty of Law and Corpus Christi College, University of Oxford, Essex Court Chambers, University of Cambridge - Department of Surgery and University of Cambridge - Department of Surgey
Downloads 13 (637,836)

Abstract:

Loading...

organ transplantation law, DCD, donation after cardiac death, pre-mortem interventions, heparin

12.

Realising Genomic Medicine: Intellectual Property Issues

Centre for Law Medicine and Life Sciences & Centre for Science and Policy Workshop Report, May 2015
Number of pages: 14 Posted: 23 Jan 2018
Kathleen Liddell
University of Cambridge - Faculty of Law
Downloads 57 (398,071)
Citation 1

Abstract:

Loading...

Human Genome, Intellectual Property, Patent Law, Patents, DNA, Gene Patents, Biobanks, Genomics, Precision Medicine, Personalised Medicine, Biobanks, Bioresources, AMP v Myriad, Mayo v Prometheus

13.

After Myriad, What Types of Claim Amendments Change a Patent Ineligible Isolated Gene Claim Into an Eligible Patent Claim That Is ‘Markedly Different’ From Nature?

35 Nature Biotechnology 820-825
Number of pages: 31 Posted: 22 May 2018
LML, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge
Downloads 36 (479,342)
Citation 1

Abstract:

Loading...

Patents, Patent Law, Biotechnology, Myriad, Gene Patents, US, Empirical Legal Research

14.

Regulation of Sub-Optimal Organ Transplantation: A Primer

Number of pages: 8 Posted: 22 Jan 2018
Kathleen Liddell, Matthew Dyson and Kourosh Saeb-Parsy
University of Cambridge - Faculty of Law, Faculty of Law and Corpus Christi College, University of Oxford and University of Cambridge - Department of Surgey
Downloads 27 (524,720)

Abstract:

Loading...

organ transplantation, organ recipients, liability, sub-optimal organs, marginal organs, medical law, tort law, product liability

15.

Continental Drift? Do European Clinical Genetic Testing Laboratories Have a Patent Problem?

European Journal of Human Genetics, 2019, University of Cambridge Faculty of Law Research Paper 32/2019
Number of pages: 12 Posted: 01 Apr 2019 Last Revised: 31 Oct 2019
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, Unversity of Cambidge, King’s College London, Dept of Social Science, Health & Medicine, LML, University of Cambridge, University of Tasmania, European Molecular Genetics Quality Network and University of Sussex
Downloads 24 (542,543)

Abstract:

Loading...

patents, genetic tests, Europe, patent law

16.

Was the Myriad Decision a ‘Surgical Strike’ on Isolated DNA Patents, or Does it Have Wider Impacts?

36(12) Nature Biotechnology 1146
Number of pages: 6 Posted: 27 Jun 2019 Last Revised: 18 Sep 2019
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 23 (548,678)
Citation 1

Abstract:

Loading...

patents, gene patents, Myriad, wider impacts, DNA, markedly different, naturally occurring compounds, empirical, Biotechnology, US

17.

IP Policies for Large Bioresources: The Fiction, Fantasy and Future of Openness

Global Genes, Local Concerns (2019), University of Cambridge Faculty of Law Research Paper No. 2/2020
Number of pages: 20 Posted: 10 Jun 2019 Last Revised: 21 May 2020
Kathleen Liddell, John Liddicoat and Matthew Jordan
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Cambridge - Faculty of Law
Downloads 19 (574,150)

Abstract:

Loading...

openness, open innovation, open science, genomics, synthetic biology

18.

Human Bodies: Regulatory Frameworks for Donations of Human Material for the Purposes of Medicine and Research

Liddell, Kathleen, Human Bodies: Regulatory Frameworks for Donations of Human Material for the Purposes of Medicine and Research (April 01, 2011).
Number of pages: 42 Posted: 23 Jan 2018
Kathleen Liddell
University of Cambridge - Faculty of Law
Downloads 16 (593,446)

Abstract:

Loading...

medical law, bioethics, human body, research, human tissue, donation, legal, comparative medical law

19.

Amicus Curiae Submission in NAFTA Proceedings Eli Lilly v. Canada

University of Cambridge Faculty of Law Research Paper No. 13/2016
Number of pages: 20 Posted: 02 Mar 2016 Last Revised: 11 May 2020
University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law and University of Vienna - Faculty of Law
Downloads 0 (726,980)

Abstract:

Loading...

intellectual property rights, patents, patent invalidation, patent revocation, utility, industrial application, new medical use inventions, selection inventions, NAFTA fair and equitable treatment, FET, state responsibility for judicial conduct, legitimate expectations, TRIPs, NAFTA

20.

How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?

How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI? / Aboy, Mateo; Cohen, Glenn ; Liddell, Kathleen; Liddicoat, J
LML, University of Cambridge, Harvard Law School, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, University of Cambridge, Harvard University - Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...

21.

Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine

Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen; Minssen, Timo; Liddicoat, Johnathan. In: Nature Biotechnology, Vol. 37, 05.2019, p. 513-518. https://doi.org/10.1038/s41587-019-0111-5
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Cambridge - Faculty of Law

Abstract:

Loading...

22.

One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?

One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections? / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen ; Davey, Neal; Liddicoat, Johnathan; Minssen, Timo. In: Nature Biotechnology, Vol. 38, 09.03.2020, p. 279–283. https://doi.or
LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, affiliation not provided to SSRN, University of Cambridge - Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

Loading...